» Articles » PMID: 10822072

Platelet-derived Microparticles in Patients with Arteriosclerosis Obliterans: Enhancement of High Shear-induced Microparticle Generation by Cytokines

Overview
Journal Thromb Res
Date 2000 May 24
PMID 10822072
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated the plasma concentrations of cytokines and platelet-derived microparticles in patients with arteriosclerosis obliterans and studied the effect of cytokines on platelet-derived microparticle generation under high shear stress. Interleukin-6 levels peaked at 48 hours after vascular surgery, while thrombopoietin started to increase at 24 to 48 hours postoperatively and peaked on the seventh day. Platelet activation markers were increased in the arteriosclerosis obliterans patients preoperatively. Levels of P-selectin and CD63 both increased further, peaking at 6 to 24 hours postoperatively. Platelet-derived microparticle levels were also increased preoperatively. At 6 hours postoperatively, the plasma level of platelet-derived microparticles was significantly increased. Plasma platelet-derived microparticle level was lower at 12 hours but only returned to the preoperative value at 7 days after grafting. There was a difference in the platelet-derived microparticle level at 7 days between patients with or without antiplatelet therapy (cilostazol). The effect of cytokines on platelet activation under high shear stress was also studied. Interleukin-6 and thrombopoietin enhanced both P-selectin expression and platelet-derived microparticle generation under high shear stress. These results suggest that platelet-derived microparticles are released by platelet activation after vascular grafting when certain cytokines increase under high shear stress and that antiplatelet therapy may reduce platelet-derived microparticle levels postoperatively.

Citing Articles

Role of circulating microparticles and cytokines in periodontitis associated with diabetes.

Cassiano B, Silveira A, Kim Y, do Amaral J, Nali L, Bachi A Front Med (Lausanne). 2024; 11:1394300.

PMID: 39253540 PMC: 11381390. DOI: 10.3389/fmed.2024.1394300.


Predictors of aneurysmal occlusion following intracranial aneurysms treatment with pipeline embolization device.

Salem M, Khorasanizadeh M, Nwajei F, Gomez-Paz S, Akamatsu Y, Jordan N Acta Neurochir (Wien). 2023; 165(10):2801-2809.

PMID: 37615726 DOI: 10.1007/s00701-023-05740-1.


Procoagulant effect of extracellular vesicles in patients after transcatheter aortic valve replacement or transcatheter aortic valve replacement with percutaneous coronary intervention.

Chi H, Shao Y, Xie F, Zhang J, Zhang G, Jiang G J Thromb Thrombolysis. 2023; 56(2):264-274.

PMID: 37284999 DOI: 10.1007/s11239-023-02835-5.


Circulating Extracellular Vesicles Are Strongly Associated With Cardiovascular Risk Markers.

Zhou R, Bozbas E, Allen-Redpath K, Yaqoob P Front Cardiovasc Med. 2022; 9:907457.

PMID: 35694679 PMC: 9178174. DOI: 10.3389/fcvm.2022.907457.


Platelet-rich plasma-derived extracellular vesicles: A superior alternative in regenerative medicine?.

Wu J, Piao Y, Liu Q, Yang X Cell Prolif. 2021; 54(12):e13123.

PMID: 34609779 PMC: 8666280. DOI: 10.1111/cpr.13123.